Brain Structure and Clinical Endpoints in Myotonic Dystrophy Type 2
Brain Structure and Clinical Endpoints in Myotonic Dystrophy Type 2
Enrolling by invitation · NCT05854433 · Registry updated 2026-07-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Brain Structure and Clinical Endpoints in Myotonic Dystrophy Type 2 | Cognition Disorders, Cognitive Dysfunction, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Muscular Disorders, Atrophic, cognitive disorder, hereditary disease, inherited neurodegenerative disorder, muscle tissue disorder, muscular dystrophy, musculoskeletal system disorder, myotonic dystrophy, myotonic dystrophy type 1, myotonic dystrophy type 2, myotonic syndrome, nervous system disorder, neurodegenerative disease, neuromuscular disease, psychiatric disorder | Enrolling by invitation | Not stated | 2026-07-14 | NCT05854433 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Institute of Neurological Disorders and Stroke (NINDS) | 370 |
| Wake Forest University Health Sciences | 284 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Wake Forest University Health Sciences | Winston-Salem | United States | 330 |